← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV20행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyPhase 3
Fluticasone Propionate (Fluticasone Propionate)
Wei-Che Ko·Skin Inflammation
ORR 0.3%
Overview
Program
Fluticasone Propionate
Overview
Company
Wei-Che Ko
Overview
Modality
ANTIBODY
Overview
Target
Skin Inflammation
Overview
Indication
Skin Inflammation; Allergic Contact Dermatitis
Overview
Phase
PHASE_3
Overview
Status
RECRUITING
MoA
Mechanism
for Their Anticancer Activity: In Silico and In Vitro Assessments
PK/PD
Species
Mouse
PK/PD
Animal (cat.)
Mouse
PK/PD
Experiment
PD
Toxicology
Species
Mouse
Toxicology
Animal (cat.)
Mouse
Toxicology
Major finding
Effects of Inhaled Corticosteroids and Long-Acting β2-Agonists on Efferocytosis and Inflammatory Cell Survival: An In Vitro Study Relevant to COPD and Lung Cancer.. Efferocytosis-the tightly regulated clearance of apoptotic cells by phagocytes-maintains tissue homeostasis and is impaired in chronic obstructive pulmonary disease (COPD), where it contributes to persistent inflammation and incr…
Clinical
Primary efficacy
ORR 0.3%
Clinical
ORR
-0.3
Clinical
Result source
ClinicalTrials.gov NCT01622231
Clinical
Data Tier / Score
A · 41
Clinical
Program phase
PHASE_3
Clinical
Clinical sync
2026년 7월 13일 (1일 전)